News

Printer Friendly Version View printer-friendly version
<< Back
Array BioPharma to Present at the Rodman & Renshaw Global Investment Conference and the Stifel Nicolaus Healthcare Conference

BOULDER, Colo., Sep 07, 2010 (BUSINESS WIRE) --

Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Robert E. Conway, will speak at the Rodman & Renshaw Global Investment Conference and the Stifel Nicolaus Healthcare Conference. The public is welcome to participate in the conferences through webcasts on the Array BioPharma website.

Event:

Rodman & Renshaw Global Investment Conference

Presenter:

Robert E. Conway, Chief Executive Officer, Array BioPharma

Date:

Monday, September 13, 2010

Time:

10:00 a.m. Eastern Time

Location:

New York Palace Hotel, New York, NY

Webcast:

www.arraybiopharma.com

Event:

Stifel Nicolaus Healthcare Conference

Presenter:

Robert E. Conway, Chief Executive Officer, Array BioPharma

Date:

Wednesday, September 15, 2010

Time:

2:05 p.m. Eastern Time

Location:

Four Seasons, Boston, MA

Webcast:

www.arraybiopharma.com

About Array BioPharma

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and inflammatory diseases. Our proprietary drug development pipeline includes clinical candidates that are designed to regulate therapeutically important target proteins and are aimed at significant unmet medical needs. For more information on Array, please go to www.arraybiopharma.com.

SOURCE: Array BioPharma Inc.

Array BioPharma Inc.
Tricia Haugeto, 303-386-1193
thaugeto@arraybiopharma.com